Drug Discovery Informatics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

The global Drug Discovery Informatics market size is expected to be worth around US$ 6.63 billion by 2030, according to a new report by Vision Research Reports.

The global Drug Discovery Informatics market size was valued at US$ 4.39 billion in 2020 and is anticipated to grow at a CAGR of 21.3% during forecast period 2021 to 2030.

Growth Factors

Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent Covid-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid Covid-19 drug discovery. Hence, the need to facilitate drug development for Covid-19 is expected to propel the industry expansion over the coming years.

Report Highlights

The discovery informatics dominated the market in 2020 with a revenue share of 59.19% due to a major focus on the development of precision medicines. involves specific medical care based on the patients’ genetic and molecular profiling. Companies, such as PerkinElmer, Inc., provide discovery informatics solutions for leveraging analytics for rapid drug discovery.

In addition, the governments in several developing countries are promoting the application of for rapid medicine discovery. For instance, in July 2020, the government of India launched Drug Discovery Hackathon (DDH). It is a training program for promoting the discovery of an effective molecule against the Covid-19 virus with the application of drug discovery informatics tools that have potential applications in identification, validation, and designing & molecule synthesis of the lead molecule.

The drug development workflow segment is expected to register the fastest CAGR of 11.69% from 2021 to 2028 owing to an increasing number of medicine candidates in the pipeline for pharmaceutical companies. These tools are used to perform specific tasks in clinical trial designing for promising the greatest improvement of overall trial performance.

The outsourced mode segment dominated the market in 2020 with a revenue share of 51.21%. The segment will expand further at a steady CAGR during the forecast period on account of an increasing number of partnerships between pharmaceutical companies and contract development and manufacturing organizations (CDMOs). Contract Research Organizations (CROs) are involved in the creation of reports on new drug entities that are subsequently used by the sponsor or drug manufacturer for submitting to the U.S. FDA.

There are benefits when pharmaceutical & biotechnology companies partner with a CRO that has the same informatics solution. The shared informatics platform between the CRO and companies helps in monitoring the progress of studies in the same way as their internal studies. This helps the company in cost-saving and productivity gain, which is expected to offer the market entities immense profitable opportunities.

The in-house mode segment is expected to witness the fastest CAGR of 11.73% from 2021 to 2028 due to the increasing adoption of informatics by large-scale companies for drug discovery owing to its advantages, such as providing direct access to information from a wide variety of sources, avoiding lengthy data compilation & reformatting, and helps in combining cross-disciplinary information.

The sequence analysis platforms emerged as a dominant segment with a revenue share of 35.22% in 2020. The segment will retain the dominant position registering the fastest CAGR over the forecast period. Bioinformatic solutions are widely employed for the development of primary & secondary databases of nucleic acid, protein as well as other biomolecule sequences. With the application of informatics software, mining and warehousing of genome sequencing is done for identifying genes and targeted proteins, which will help in the development of potential drugs.

The sequence analysis platforms emerged as a dominant segment with a revenue share of 35.22% in 2020. The segment will retain the dominant position registering the fastest CAGR over the forecast period. Bioinformatic solutions are widely employed for the development of primary & secondary databases of nucleic acid, protein as well as other biomolecule sequences. With the application of informatics software, mining and warehousing of genome sequencing is done for identifying genes and targeted proteins, which will help in the development of potential drugs.

In addition, basic drug discovery research requires the employment of different databases along with sequence analysis tools, such as CLUSTALW, BLAST, and FASTA. Also, the launch of new and advanced software is contributing to the segment growth. For instance, in July 2019, Certara launched a new version of D360, a scientific informatics platform (version 19.6) for drug discovery & development. The platform enables alignment, representation, and analysis of small sections of proteins and peptide sequences.

The informatics platform enables users to arrange peptide sequences based on color code by property. Molecular modeling is increasingly gaining popularity owing to its wide application in the drug discovery process. These tools are applied for the modeling and simulation of biological systems and small molecules for understanding & predicting their behavior at a molecular level. In addition, they accelerate the cost-efficiency of hit discovery and hit-to-lead optimization.

North America accounted for the largest market share of 39.30% in 2020; growth in the region can be attributed to several factors, such as high incidence of infectious diseases, rapid adoption of new & advanced tools for R&D, and the presence of prominent players. Moreover, companies in the region are focusing on joint ventures and research collaborations, which will boost the market growth in the coming years.

Key Players

  • Certara

  • Boehringer Ingelheim International GmbH

  • Infosys Ltd.

  • Charles River Laboratories

  • Collaborative Drug Discovery, Inc.

  • Eurofins DiscoverX Products

  • Jubilant Biosys

  • Selvita

  • Novo Informatics Pvt. Ltd.

  • ChemAxon Ltd.

  • Albany Molecular Research Inc.

  • Oracle

  • Accenture

  • Agilent Technologies, Inc.

  • Illumina, Inc.

Market Segmentation

  • Workflow Outlook 

    • Discovery Informatics

      • Identification, Validation, & Assay Development Informatics

      • Lead Generation

    • Development Informatics

      • Lead Optimization

      • FHD Preparation

      • Phase IA

      • Phase IB/2

  • Mode Outlook

    • Outsourced

    • In-house

  • Services Outlook 

    • Sequence Analysis Platforms

    • Molecular Modeling

    • Docking

    • Clinical Trial Data Management

    • Other Services

  • Regional Outlook

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

    • Middle East & Africa

      • South Africa

The Drug Discovery Informatics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Drug Discovery Informatics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Drug Discovery Informatics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Discovery Informatics market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Drug Discovery Informatics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Drug Discovery Informatics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Drug Discovery Informatics by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Drug Discovery Informatics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Drug Discovery Informatics market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Drug Discovery Informatics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Drug Discovery Informatics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Drug Discovery Informatics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Drug Discovery Informatics market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Drug Discovery Informatics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Drug Discovery Informatics market. These factors have benefited the growth of the global market for Drug Discovery Informatics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Drug Discovery Informatics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Drug Discovery Informatics are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Report Detail

Proceed To Buy

USD 4500
USD 7900

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers